FDA.reportPublic FDA data

METHYLCELLULOSE (4000 MPA.S)

Substance profile for UNII MRJ667KA5E, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Substance Identity#

UNII
MRJ667KA5E
Preferred term
METHYLCELLULOSE (4000 MPA.S)
Registry number
9004-67-5
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
Polymer substance not supported

Chemical And Database Identifiers#

RxCUI
1297402
PubChem
0
INN ID
0

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
RxNorm1297402mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1297402
FDA Substance Registration SystemMRJ667KA5Eprecision.fda.gov/uniisearch/srs/unii/MRJ667KA5E

DailyMed Socrata Ingredients#

Ingredient, Type, DailyMed label table
IngredientTypeDailyMed labelSPL version
METHYLCELLULOSE (4000 MPA.S)INACTIVE INGREDIENTScarScreen1
METHYLCELLULOSE (4000 CPS)INACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
METHYLCELLULOSE (4000 CPS)INACTIVE INGREDIENTSULFACETAMIDE SODIUM OPHTHALMIC SOLUTION USP, 10%4
METHYLCELLULOSE (4000 CPS)INACTIVE INGREDIENTCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]10
METHYLCELLULOSE (4000 MPA.S)ACTIVE INGREDIENTCITRUCEL (METHYLCELLULOSE) TABLET [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]9
METHYLCELLULOSE (4000 MPA.S)ACTIVE MOIETYCITRUCEL (METHYLCELLULOSE) TABLET [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]9
METHYLCELLULOSE (4000 MPA.S)ACTIVE INGREDIENTCITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]6
METHYLCELLULOSE (4000 MPA.S)ACTIVE MOIETYCITRUCEL (METHYLCELLULOSE) POWDER, FOR SOLUTION [GLAXOSMITHKLINE CONSUMER HEALTHCARE LP]6
METHYLCELLULOSE (4000 MPA.S)INACTIVE INGREDIENTT.R.U.E. TEST THIN-LAYER RAPID USE PATCH TEST (STANDARDIZED ALLERGENIC) KIT [SMARTPRACTICE DENMARK APS]5
METHYLCELLULOSE (4000 CPS)INACTIVE INGREDIENTSULFACETAMIDE SODIUM SOLUTION [FALCON PHARMACEUTICALS, LTD.]2
METHYLCELLULOSE (4000 MPA.S)ACTIVE INGREDIENTFIBER THERAPY (METHYLCELLULOSE) POWDER, FOR SOLUTION [MAJOR PHARMACEUTICALS]1
METHYLCELLULOSE (4000 MPA.S)ACTIVE MOIETYFIBER THERAPY (METHYLCELLULOSE) POWDER, FOR SOLUTION [MAJOR PHARMACEUTICALS]1
METHYLCELLULOSE (4000 CPS)ACTIVE MOIETYHEALTH MART FIBER CAPLETS (METHYLCELLULOSE) TABLET [MCKESSON]1
METHYLCELLULOSE (4000 CPS)ACTIVE INGREDIENTHEALTH MART FIBER CAPLETS (METHYLCELLULOSE) TABLET [MCKESSON]1
METHYLCELLULOSE (4000 MPA.S)INACTIVE INGREDIENTSTRATUSCARE ANTACID AND ANTIGAS (ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE, AND SIMETHICONE) SUSPENSION [STRATUS PHARAMCEUTICALS]1
METHYLCELLULOSE (4000 MPA.S)INACTIVE INGREDIENTSTRATUSCARE ANTACID AND ANTIGAS (DIMETHICONE, ALUMINUM HYDROXIDE, AND MAGNESIUM HYDROXIDE) SUSPENSION [STRATUS PHARAMCEUTICALS]1
METHYLCELLULOSE (4000 MPA.S)INACTIVE INGREDIENTSTRATUSCARE ANTACID AND ANTIGAS REGULAR STRENGTH (DIMETHICONE, ALUMINUM HYDROXIDE, AND MAGNESIUM HYDROXIDE) SUSPENSION [STRATUS PHARMACEUTICALS]1
METHYLCELLULOSE (4000 CPS)ACTIVE MOIETYSUNMARK FIBER LAXATIVE (METHYLCELLULOSE) TABLET [MCKESSON]1
METHYLCELLULOSE (4000 CPS)ACTIVE INGREDIENTSUNMARK FIBER LAXATIVE (METHYLCELLULOSE) TABLET [MCKESSON]1

Inactive Ingredient Database#

Browse recovered IID releases and source provenance.

Current IID rows for UNII MRJ667KA5E page 1 of 1 ยท 4 matching rows.

Ingredient, UNII, CAS table
IngredientUNIICASDosage formRoutePotencyMaximum daily exposure
METHYLCELLULOSE (4000 MPA.S)MRJ667KA5E9004675SOLUTION/ DROPSOPHTHALMIC0.5 %w/v
METHYLCELLULOSE (4000 MPA.S)MRJ667KA5E9004675SUSPENSIONORAL100 mg
METHYLCELLULOSE (4000 MPA.S)MRJ667KA5E9004675TABLET, DELAYED RELEASEORAL101 mg
METHYLCELLULOSE (4000 MPA.S)MRJ667KA5E9004675CREAMTOPICAL1.3 %w/w